Key Takeaways:
- Corteva reported full-year 2025 GAAP net sales of $17.40 billion, up 3% year-over-year.
- Operating EBITDA reached $3.85 billion, while Operating EPS was $3.34 on a non-GAAP basis.
- Seed and Crop Protection both delivered organic growth, supported by new products and biologicals.
- Strong cash generation enabled over $1.5 billion returned to shareholders in 2025.
- Corteva refined its 2026 guidance, targeting operating EBITDA of $4.0–$4.2 billion.
Corteva Delivers Full-Year Growth Despite Mixed Market Conditions
Corteva, Inc. (NYSE: CTVA) reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting growth across regions and continued demand for its seed and crop protection portfolios.
For full-year 2025, Corteva reported GAAP income from continuing operations of $1.20 billion, with earnings per share of $1.75. Net sales increased 3% year-over-year, while organic sales rose 4%, supported by gains in all regions. On a non-GAAP basis, operating EBITDA reached $3.85 billion, up 14% compared to 2024, and operating EPS increased 30% to $3.34.
Chuck Magro, Chief Executive Officer of Corteva, said the results reflected sustained execution across the business. “Our delivery of strong second-half and full-year results reflects continued demand for our differentiated technologies and disciplined execution across the company,” he said.
13 Comments